Successful Treatment of a Patient With Brain Metastasis From Ovarian Cancer With BRCA Wild Type Using Niraparib: A Case Report and Review of the Literature

Successful Treatment of a Patient With Brain Metastasis From Ovarian Cancer With BRCA Wild Type Using Niraparib: A Case Report and Review of the Literature

BackgroundBrain metastases from ovarian cancer are extremely rare and have a very poor prognosis. A multimodal approach (surgery combined with radiotherapy and chemotherapy) yields the best results in reducing neurological symptoms and prolonging survival. Unfortunately, not every patient receives a...

Full description

Bibliographic Details
Main Authors: Zhenhua Zhang, Muying Xu, Abbas Sakandar, Xiuju Du, Huailin He, Wenfeng He, Dan Li, Qinglian Wen
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Oncology
Subjects:
ovarian carcinoma
niraparib
brain metastases
monotherapy
survival
PARP inhibitors
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.873198/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.873198/full

Similar Items